The rising incidence of life-threatening infectious diseases, increasing funding and investments in cell-based research from government and corporate, high demand for cell analysis products by end-users, emerging Asia-Pacific market, emerging cell analysis service providers and introduction of automation tech...
-
How fast the market of your interest is growing?
Key drivers behind the growth..
-
What are your biggest Challenges?Identify the key problems.. -
What are your Revenue pockets?Areas you need to bet.. -
What are your Competitors doing?Know your competitive edge.. -
Who is your Customer?Get Their changing preferences..
Intelligence Quotient for Innovation Research and Consultancy
Buy Doxycycline over the counter
IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.
We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.
what we offer
Report Store
Healthcare is an ever changing domain with an explosion in knowledge and breakthrough discoveries. Hence, it has become a major thrust area for the global giants in the pharmaceutical, biotechnology and medical devices industries and also for corporates involved in research and development of new products.
IQ4I's focus areas in Healthcare include Pharmaceuticals, biotechnology, Medical devices and Healthcare IT. Since these domains cater to humans, they are subject to stringent regulatory mechanisms requiring highly specialized skills in knowledge processing, with superior quality and adherence to global standards.
IQ4I
Latest Reports
Live-cell imaging, single-cell analysis, and high content screening (HCS) are few technologies where individual cells are analyzed for in their natural states are gaining prominence in the cell analysis market.
Electrosurgical devices use electrical energy where alternating current is used to cut, coagulate, desiccate tissue resulting in precise cut and limited blood loss. Increasing ageing population, cosmetic surgery, demand for minimally invasive surgery, patients suffering from obesity and technological advancements are driving the market growth.
Excipients are inactive substances helping modulate solubility, bio-availability and stability of active substances in a drug and form the major part of any medicinal product.
Glucose Monitoring consist of products that are essential for patients suffering diabetes. With the projected rise in aged population and awareness about such conditions, the market is focused on growing with newer technology and improved products.
The demand for cost effective alternatives for animal testing and increasing approval of biologics and biosimilars is driving the growth of cell-based assays global market.
Active Pharmaceutical Ingredients (API) Global Market estimated to be worth $307.2 billion by 2025. API market is segmented by synthesis including synthetic chemicals, HPAPI and biotech API.
Small molecules continue to dominate the global therapeutics market, many molecules going off-patent is paving way for introduction of generics creating a favorable opportunity for the Pharmaceutical contract manufacturers.
Increasing demand for minimally invasive surgical procedure leading fast recovery and reduced hospital stays, technological innovations offering a wider scope of applications for endoscopy, the rise in obese population preferring bariatric surgery for weight reduction are the factors driving the market growth.
Cell lines are one of the major tools in pharmaceutical research and have wide range of applications in gene function studies, drug discovery assays, the production of biotherapeutics and diagnostics.
Many large and small pharmaceutical companies are turning to outsourcing the drug manufacture process to reduce capital investments on capacities and focus more on their core competencies.
IQ4I
Latest News
The news coverage mentions the IQ4I Research's findings on the "Contrast Agents/Media Global Report-Forecast to 2025". For further information please . https://www.iq4i.com/reports-category/pharmaceuticals/r/180...
IQ4I
Clientele
Offering solutions to >500 clients from the U.S., Europe, Japan, Korea, Singapore and Australia in realizing the market potential and competitive intelligence across healthcare domains (Medical Technologies, Pharmaceutical, Biotech and Life Sciences).
